
ZCL278
CAS No. 587841-73-4
ZCL278 ( ZCL 278 | ZCL-278 )
产品货号. M15167 CAS No. 587841-73-4
一种有效的细胞渗透性 Cdc42 特异性小分子抑制剂 (Kd=6.4 uM)。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥373 | 有现货 |
![]() ![]() |
10MG | ¥583 | 有现货 |
![]() ![]() |
25MG | ¥1118 | 有现货 |
![]() ![]() |
50MG | ¥1887 | 有现货 |
![]() ![]() |
100MG | ¥2649 | 有现货 |
![]() ![]() |
200MG | ¥4236 | 有现货 |
![]() ![]() |
500MG | ¥6869 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称ZCL278
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述一种有效的细胞渗透性 Cdc42 特异性小分子抑制剂 (Kd=6.4 uM)。
-
产品描述A potent, cell-permeable Cdc42-specific small-molecule inhibitor (Kd=6.4 uM); specifically targets Cdc42–intersectin interaction and inhibits Cdc42-mediated cellular processes, including Golgi organization and cell motility.
-
体外实验ZCL278 as a potent, cell-permeable Cdc42-specific inhibitor that suppresses actin-based cellular functions, including Golgi organization and cell motility.In Swiss 3T3 fibroblast cultures, ZCL278 abolishes microspike formation and disrupted GM130-docked Golgi structures, two of the most prominent Cdc42-mediated subcellular events. ZCL278 reduces the perinuclear accumulation of active Cdc42 in contrast to NSC23766, a selective Rac inhibitor. ZCL278 suppresses Cdc42-mediated neuronal branching and growth cone dynamics as well as actin-based motility and migration in a metastatic prostate cancer cell line (i.e., PC-3) without disrupting cell viability. ZCL278 inhibits Cdc42 function as an entry inhibitor for Junin virus (JUNV) and for vesicular stomatitis virus, lymphocytic choriomeningitis virus, and dengue virus but not for the nonenveloped poliovirus. In cells, ZCL278 is shown to efficiently inhibit chemically induced filopodium formation, a process dependent on Cdc42 activity. Dose-response experiments are first carried out in Vero cells, and while ZCL278 is not toxic at concentrations up to 200 μM, ZCL278 inhibits JUNV with IC50 of ~14 μM, as measured by flow cytometry.
-
体内实验ZCL278 reduces the JUNV RNA load in the spleen more than 33-fold, with JUNV RNA being undetectable in 5 out of 8 mice. These results are similar to those seen in Gabapentin-treated mice, demonstrating that ZCL278 can abrogate JUNV replication.
-
同义词ZCL 278 | ZCL-278
-
通路MAPK/ERK Signaling
-
靶点Ras
-
受体Cdc42GTPase
-
研究领域Cancer
-
适应症——
化学信息
-
CAS Number587841-73-4
-
分子量584.8937
-
分子式C21H19BrClN5O4S2
-
纯度>98% (HPLC)
-
溶解度10 mM in DMSO
-
SMILESO=C(NC(NC1=CC=C(S(=O)(NC2=NC(C)=CC(C)=N2)=O)C=C1)=S)COC3=CC=C(Br)C=C3Cl
-
化学全称Acetamide, 2-(4-bromo-2-chlorophenoxy)-N-[[[4-[[(4,6-dimethyl-2-pyrimidinyl)amino]sulfonyl]phenyl]amino]thioxomethyl]-
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Friesland A, et al. Proc Natl Acad Sci U S A. 2013 Jan 22;110(4):1261-6.
2. Liu X, et al. Cell Physiol Biochem. 2015;36(4):1613-27.